Inozyme Pharma Stock Forecast - Polynomial Regression
| INZYDelisted Stock | USD 4.00 0.00 0.00% |
The Polynomial Regression forecasted value of Inozyme Pharma on the next trading day is expected to be 3.31 with a mean absolute deviation of 0.36 and the sum of the absolute errors of 21.91. Inozyme Stock Forecast is based on your current time horizon.
Inozyme |
Inozyme Pharma Polynomial Regression Price Forecast For the 25th of July
Given 90 days horizon, the Polynomial Regression forecasted value of Inozyme Pharma on the next trading day is expected to be 3.31 with a mean absolute deviation of 0.36, mean absolute percentage error of 0.25, and the sum of the absolute errors of 21.91.Please note that although there have been many attempts to predict Inozyme Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Inozyme Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Inozyme Pharma Stock Forecast Pattern
| Backtest Inozyme Pharma | Inozyme Pharma Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Inozyme Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Inozyme Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.7089 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3592 |
| MAPE | Mean absolute percentage error | 0.1842 |
| SAE | Sum of the absolute errors | 21.9123 |
Predictive Modules for Inozyme Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inozyme Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Inozyme Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inozyme Pharma stock to make a market-neutral strategy. Peer analysis of Inozyme Pharma could also be used in its relative valuation, which is a method of valuing Inozyme Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Inozyme Pharma Market Strength Events
Market strength indicators help investors to evaluate how Inozyme Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inozyme Pharma shares will generate the highest return on investment. By undertsting and applying Inozyme Pharma stock market strength indicators, traders can identify Inozyme Pharma entry and exit signals to maximize returns.
Inozyme Pharma Risk Indicators
The analysis of Inozyme Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inozyme Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inozyme stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 9.87 | |||
| Semi Deviation | 2.74 | |||
| Standard Deviation | 26.82 | |||
| Variance | 719.55 | |||
| Downside Variance | 42.27 | |||
| Semi Variance | 7.5 | |||
| Expected Short fall | (14.59) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Inozyme Stock
If you are still planning to invest in Inozyme Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inozyme Pharma's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |